APH vs COLL
Amphenol Corporation (APH) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
APH currently screens at market cap $170.77B and trailing P/E 39.9. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the APH and COLL stock pages for the full models.
Not investment advice.